Lensar (LNSR) Non-Current Assets (2019 - 2026)
Lensar's (LNSR) quarterly Non-Current Assets came in at $23.8 million in Q1 2026, little changed year-on-year from $23.8 million in Q1 2025, and down 3.4% on a QoQ basis from $24.7 million in Q4 2025.
Lensar (LNSR) Non-Current Assets (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Non-Current Assets data on file, last reported at $23.8 million in Q1 2026.
- On a quarterly basis, Non-Current Assets changed 0.2% year-over-year to $23.8 million in Q1 2026; TTM through Mar 2026 was $98.8 million, a 7.53% increase from a year earlier, with the FY2025 full-year figure at $24.7 million, up 1.4% from the prior year.
- Non-Current Assets for Q1 2026 stood at $23.8 million, down from $24.7 million in the prior quarter.
- Over the last five years, Non-Current Assets for LNSR reached as high as $25.8 million in Q3 2025 and fell as low as $21.2 million in Q2 2024.
- Historically, Non-Current Assets has averaged $23.2 million across 5 years, with a median of $23.1 million in 2023.
- Across the five-year window, Non-Current Assets decreased 6.22% in 2023 and grew 15.92% in 2025, its largest moves.
- Year by year, Non-Current Assets stood at $22.1 million in 2022, then climbed by 4.58% to $23.1 million in 2023, then increased by 5.09% to $24.3 million in 2024, then grew by 1.4% to $24.7 million in 2025, then slipped by 3.4% to $23.8 million in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $23.8 million in Q1 2026, $24.7 million in Q4 2025, and $25.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 23.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.82 Mn |
| Dec 31, 2025 | 24.66 Mn |
| Sep 30, 2025 | 25.78 Mn |
| Jun 30, 2025 | 24.55 Mn |
| Mar 31, 2025 | 23.77 Mn |
| Dec 31, 2024 | 24.32 Mn |
| Sep 30, 2024 | 22.62 Mn |
| Jun 30, 2024 | 21.18 Mn |
| Mar 31, 2024 | 23.70 Mn |
| Dec 31, 2023 | 23.14 Mn |
| Sep 30, 2023 | 22.21 Mn |
| Jun 30, 2023 | 22.03 Mn |
| Mar 31, 2023 | 21.99 Mn |
| Dec 31, 2022 | 22.13 Mn |
| Sep 30, 2022 | 22.63 Mn |
| Jun 30, 2022 | 23.49 Mn |
| Mar 31, 2022 | 21.75 Mn |
| Dec 31, 2021 | 21.65 Mn |
| Sep 30, 2021 | 21.44 Mn |
| Jun 30, 2021 | 20.92 Mn |